Suchergebnisse - "Götschi, Andrea"

PubPharm (11)

1

Early axial spondyloarthritis according to the ASAS consensus definition : characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry

enthalten in: RMD open | 2023

von Ciurea, A. | Götschi, A. | Bräm, R. | +11

2

Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting : An individual patient level analysis of the OVID and ETHIC trials

enthalten in: Thrombosis research | 2023

von Barco, S. | Virdone, S. | Götschi, A. | +34

3

Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting : an individual patient level analysis of the OVID and ETHIC trials

enthalten in: Thrombosis research | October 2023

von Barco, S. | Virdone, S. | Götschi, A. | +33

4

Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis

enthalten in: The Cochrane database of systematic reviews | 2023

von Reeve, K. | On, B. | Havla, J. | +8

5

Deep transformation models for functional outcome prediction after acute ischemic stroke

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2023

von Herzog, L. | Kook, L. | Götschi, A. | +6

6

Long-term neurodevelopmental outcome and serial cerebral magnetic resonance imaging assessment in Fontan patients at school age

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2023

von Reich, B. | Schwan, S. | Heye, K. | +9

7

Impact of sex on spinal radiographic progression in axial spondyloarthritis : a longitudinal Swiss cohort analysis over a period of 10 years

enthalten in: RMD open | 2023

von Ensslin, C. | Micheroli, R. | Kissling, S. | +12

8

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry

enthalten in: RMD open | 2023

von Ciurea, A. | Götschi, A. | Kissling, S. | +7

9

Enoxaparin for outpatients with COVID-19 : 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial

enthalten in: Thrombosis research | 2023

von Voci, D. | Götschi, A. | Held, U. | +22

10

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID) : a randomised, open-label, parallel-group, multicentre, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Barco, S. | Voci, D. | Held, U. | +70

CommentIn: Lancet Haematol. 2022 Aug;9(8):e551-e553. - PMID 35779559